If you are interested in assisting the protocol development or participating in one of the following trials once activated, please contact the relevant Trial Chairperson.

Phase III study comparing post-operative radiotherapy to no post-operative radiotherapy in patients with histologically proven mediastinal involvement and completely resected non small cell lung cancer (LUNG ART- Lung Adjuvant Radiotherapy Trial)

Trial Chairperson
Assoc Prof David Ball
Radiation Oncology
Peter MacCallum Cancer Centre
St Andrew’s Place
East Melbourne VIC 3002
Tel: +61 3 9656 1111 Fax: +61 3 9656 1424
Email: David.Ball@petermac.org

SUPREMO (Selective Use of Postoperative Radiotherapy aftEr MastectOmy) BIG 2-04 (ANZBCTG)

Trial Chairperson
Dr Boon Chua
Division of Radiation Oncology
Peter MacCallum Cancer Centre
Tel: +61 3 9656 1111 Fax: +61 3 9656 1424
Email: Boon.Chua@petermac.org

QUARTZ – Quality of life After RadioTherapy and/or Steroids (previously called OSCAR)

Trial Chairperson
Dr Tanya Holt
Division of Radiation Oncology
Mater QRI Brisbane
Tel: +61 7 3840 3222 Fax: +61 7 3840 3399
Email: Tanya_holt@health.qld.gov.au

A randomised comparison of anastrozole commenced before and continued during radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy.(Brief name: TROG STARS Breast trial)

Trial Chairperson
Dr Peter Graham
Cancer Care Centre
St George Hospital
Kogarah NSW 2217
Tel: +61 2 9350 3934 Fax: +61 2 9350 3958
 Email: Peter.Graham@SESIAHS.health.nsw.gov.au

A multicentre trial of the use of Sentinel Lymph Node Biopsy (SLNB) to determine the Radiotherapy (RT) volumes for treatment of cN0-1 Squamous Cell Cancer (SCC) of the anus

Trial Chairperson
Dr Sean Bydder
Department of Radiation Oncology
Sir Charles Gairdner Hospital
Tel: +61 8 9346 4900 Fax: +61 8 9346 3402
Email: Sean.Bydder@health.wa.gov.au

Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – a randomised phase III trial

Trial Chairperson
Dr Gerald Fogarty
Radiation Oncology Mater Hospital - North Sydney
Tel: +61 2 9929 2600 Fax: +61 2 9929 2687
Email: Gerald.Fogarty@i-med.com.au

A Phase II study of cetuximab, carboplatin and concomitant boost radiotherapy for locally advanced Head and Neck Squamous Cell Carcinoma

Trial Chairperson
Dr June Corry
Department of Radiation Oncology
Peter MacCallum Cancer Centre
Tel: +61 3 9656 1111 Fax: +61 3 9656 1424
Email: June.Corry@petermac.org

Radiotherapy with Humidification in head and neck cancer

Trial Chairperson
Dr Andrew Macann
Radiation Oncology Auckland Hospital
Tel: +64 9 379 7440 Fax: +64 9 307 4926
Email: amacann@adhb.govt.nz

Hypofractionated radiation and concurrent Temozolomide chemotherapy in patients with newly-diagnosed glioblastoma multiforme unsuitable for conventionally-fractionated radiotherapy

Trial Chairperson
Dr Claire Phillips
Department of Radiation Oncology
Peter MacCallum Cancer Centre
Tel: +61 3 9656 1111 Fax: +61 3 9656 1424
Email: Claire.Phillips@petermac.org

Phase II study of zoledronic acid followed by delayed palliative radiotherapy (if necessary) in patients with painful bone metastases (from non-breast, non-prostate solid tumour malignancies)

Trial Chairperson
Dr Mathew Seel
Department of Radiation Oncology
Peter MacCallum Cancer Centre
Tel: +61 3 9656 1111 Fax: +61 3 9656 1424
Email: Matthew.Seel@petermac.org

RAVES: Radiotherapy – Adjuvant Versus Early Salvage

Trial Chairperson
Dr Maria Pearse
Radiation Oncology Auckland Hospital
Tel: +64 9 3074949 Fax: +64 9 307 4926
Email: mariap@adhb.govt.nz

[ Trials Approved for Further Development - Home ]